CRYSTAL FORMS OF tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, PROCESSES OF MAKING SUCH FORMS, AND THEIR PHARMACEUTICAL COMPOSITIONS
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application PCT/IB2016/001181, filed Jul 19, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,413,519 | CRYSTAL FORMS OF tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, PROCESSES OF MAKING SUCH FORMS, AND THEIR PHARMACEUTICAL COMPOSITIONS In force · High confidence | Anavex Life Sciences Corp. | In force | High confidence | ||
| US 10,966,952 | Crystal Forms of TETRAHYDRO-N,N-DIMETHYL-2,2-Diphenyl-3-Furanmethanamine Hydrochloride, Processes of Making Such Forms, and Their Pharmaceutical Compositions In force · High confidence | Anavex Life Sciences Corp. | In force | High confidence | ||
| US 12,759,986 | Crystal Forms of Tetrahydro-N, N-DIMETHYL-2, 2-Diphenyl-3-Furanmethanamine, Processes of Making Such Forms, and Their Pharmaceutical Compositions In force · High confidence | Anavex Life Sciences Corp. | In force | High confidence | ||
| US 11,661,405 | Crystal Forms of TETRAHYDRO-N,N-DIMETHYL-2,2-Diphenyl-3-Furanmethanamine Hydrochloride, Processes of Making Such Forms, and Their Pharmaceutical Compositions In force · High confidence | Anavex Life Sciences Corp. | In force | High confidence |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.